Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease
- Conditions
- Non-Alcoholic Fatty Liver Disease
- Interventions
- Other: Dietary intervention
- Registration Number
- NCT04400864
- Lead Sponsor
- Rabin Medical Center
- Brief Summary
Non- alcoholic fatty liver disease (NAFLD) is one of metabolic syndrome manifestation, and has become the leading cause for cirrhosis and the need for liver transplantation.
The Mediterranean diet showed in many trials its benefit in the treatment of the metabolic syndrome and NAFLD. The Paleolithic Diet includes meat, fish, fruits, vegetables, nuts and seeds and avoidance of processed food and most of carbohydrates. In some studies this diet seemed to decrease triglycerides levels and improve insulin resistance.
The aim of this study is to evaluate the influance of the paleolithic diat for the treatment of NAFLD, as shown in the Mediterranean Diet.
- Detailed Description
Recruitment of 60 patients with the diagnosis NAFLD from clinics in Rabin Medical center, aged 18-65.
Two study groups- Mediterranean Diet and Paleolithic Diet The dietitian will assign randomly for the study groups, and will assess diet adherence within 6 weeks of the trial and in its end- after 3 months.
blood test for liver enzymes, lipids, crp, mda and HbA1C, will be taken at recruitment and after 3 months.
Ultrasound and elastography will be tested at recruitment and after 3 months, to evaluate the degree of the fatty liver, by a the same doctor who is blind to the study groups.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- NAFLD
- pregnancy
- Chronic kidney disease
- post transplant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mediterranean Diet Dietary intervention Nutritional guidelines based on the principals of the Mediterranean Diet Paleolithic Diet Dietary intervention Nutritional guidelines based on the principals of thePaleolithic Diet
- Primary Outcome Measures
Name Time Method Changes in the severity of the fatty liver measured by ultrasound and elastography. 3 months Changes in fatty liver severity score according to ultrasound wave intensity analysis- light ; moderate ; severe.
- Secondary Outcome Measures
Name Time Method Changes in HbA1C 3 months Blood tests for HbA1C are taken at the beginning and the end of the trial, and analyzed for changes.
Changes in Triglycerides levels 3 months Blood tests for Triglycerides are taken at the beginning and the end of the trial, and analyzed for changes.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Rabin Medical Center
🇮🇱Petah tikva, Israel